Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

Archive ouverte

Le Voyer, Tom | Parent, Audrey, V | Liu, Xian | Cederholm, Axel | Gervais, Adrian | Rosain, Jérémie | Nguyen, Tina | Perez Lorenzo, Malena | Rackaityte, Elze | Rinchai, Darawan | Zhang, Peng | Bizien, Lucy | Hancioglu, Gonca | Ghillani-Dalbin, Pascale | Charuel, Jean-Luc | Philippot, Quentin | Gueye, Mame Sokhna | Maglorius Renkilaraj, Majistor Raj Luxman | Ogishi, Masato | Soudée, Camille | Migaud, Mélanie | Rozenberg, Flore | Momenilandi, Mana | Riller, Quentin | Imberti, Luisa | Delmonte, Ottavia, M | Müller, Gabriele | Keller, Baerbel | Orrego, Julio | Franco Gallego, William Alexander | Rubin, Tamar | Emiroglu, Melike | Parvaneh, Nima | Eriksson, Daniel | Aranda-Guillen, Maribel | Berrios, David, I | Vong, Linda | Katelaris, Constance, H | Mustillo, Peter | Raedler, Johannes | Bohlen, Jonathan | Bengi Celik, Jale | Astudillo, Camila | Winter, Sarah | Boisson-Dupuis, Stéphanie | Oksenhendler, Eric | Okada, Satoshi | Caluseriu, Oana | Ursini, Mathilde Valeria | Ballot, Eric | Lafarge, Geoffroy | Freiberger, Tomas | Arango-Franco, Carlos, A | Levy, Romain | Aiuti, Alessandro | Al-Muhsen, Saleh | Al-Mulla, Fahd | Andreakos, Evangelos | Arias, Andrés, A | Feldman, Hagit Baris | Bastard, Paul | Bondarenko, Anastasia | Borghesi, Alessandro | Bousfiha, Ahmed, A | Brodin, Petter | Bryceson, Yenan | Casari, Giorgio | Christodoulou, John | Colobran, Roger | Condino-Neto, Antonio | Fellay, Jacques | Flores, Carlos | Franco, José Luis | Haerynck, Filomeen | Halwani, Rabih | Hammarström, Lennart | Heath, James, R | Hsieh, Elena, W Y | Itan, Yuval | Kaja, Elżbieta | Kisand, Kai | Ku, Cheng-Lung | Ling, Yun | Lau, Yu-Lung | Mansouri, Davood | Meyts, Isabelle | Milner, Joshua, D | Mogensen, Trine, H | Novelli, Antonio | Novelli, Giuseppe | Okamoto, Keisuke | Ozcelik, Tayfun | de Diego, Rebeca Perez | Perez-Tur, Jordi | Perlin, David, S | Prando, Carolina | Pujol, Aurora | Quintana-Murci, Lluis | Renia, Laurent | Resnick, Igor | Rodríguez-Gallego, Carlos | Sancho-Shimizu, Vanessa | Sediva, Anna | Seppänen, Mikko, R J | Shahrooei, Mohammed | Shcherbina, Anna | Palacín, Pere Soler | Pesole, Graziano | Spaan, András, N | Su, Helen, C | Tancevski, Ivan | Tayoun, Ahmad Abou | Amara, Ali | Gorochov, Guy | Temel, Şehime Gülsün | Thorball, Christian | Tiberghien, Pierre | Trouillet-Assant, Sophie | Turvey, Stuart | Uddin, K, M Furkan | Uddin, Mohammed, J | van de Beek, Diederik | Vidigal, Mateus | Vinh, Donald, C | von Bernuth, Horst | Wauters, Joost | Zatz, Mayana | Zhang, Shen-Ying | Ng, Lisa, F P | Mclean, Catriona | Guffroy, Aurélien | Derisi, Joseph, L | Yu, David | Miller, Corey | Feng, Yi | Guichard, Audrey | Béziat, Vivien | Bustamante, Jacinta | Pan-Hammarström, Qiang | Zhang, Yu | Rosen, Lindsey, B | Holland, Steve, M | Bosticardo, Marita | Kenney, Heather | Castagnoli, Riccardo | Slade, Charlotte, A | Boztuğ, Kaan | Mahlaoui, Nizar | Latour, Sylvain | Abraham, Roshini, S | Lougaris, Vassilios | Hauck, Fabian | Atschekzei, Faranaz | Sogkas, Georgios | Poli, M. Cecilia | Slatter, Mary, A | Palterer, Boaz | Keller, Michael, D | Pinzon-Charry, Alberto | Sullivan, Anna | Droney, Luke | Suan, Daniel | Wong, Melanie | Kane, Alisa | Hu, Hannah | Ma, Cindy | Grombiříková, Hana | Ciznar, Peter | Dalal, Ilan | Aladjidi, Nathalie | Hie, Miguel | Lazaro, Estibaliz | Franco, José, Luis | Keles, Sevgi | Malphettes, Marion | Pasquet, Marlene | Maccari, Maria Elena | Meinhardt, Andrea | Ikinciogullari, Aydan | Shahrooei, Mohammad | Celmeli, Fatih | Frosk, Patrick | Goodnow, Christopher, C | Gray, Paul, E | Belot, Alexandre | Kuehn, Hye Sun | Rosenzweig, Sergio, D | Miyara, Makoto | Licciardi, Francesco | Servettaz, Amélie | Barlogis, Vincent | Le Guenno, Guillaume | Herrmann, Vera-Maria | Kuijpers, Taco | Ducoux, Grégoire | Sarrot-Reynauld, Françoise | Schuetz, Catharina | Cunningham-Rundles, Charlotte | Rieux-Laucat, Frédéric | Tangye, Stuart, G | Sobacchi, Cristina | Doffinger, Rainer | Warnatz, Klaus | Grimbacher, Bodo | Fieschi, Claire | Berteloot, Laureline | Bryant, Vanessa, L | Trouillet Assant, Sophie | Neven, Benedicte | Abel, Laurent | Zhang, Qian | Boisson, Bertrand | Cobat, Aurélie | Jouanguy, Emmanuelle | Kampe, Olle | Roifman, Chaim, M | Landegren, Nils | Notarangelo, Luigi, D | Anderson, Mark, S | Casanova, Jean-Laurent | Puel, Anne

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency produce autoantibodies that neutralize type I interferons (IFNs) 1,2 , conferring a predisposition to life-threatening COVID-19 pneumonia 3 . Here we report that patients with autosomal recessive NIK or RELB deficiency, or a specific type of autosomal-dominant NF-κB2 deficiency, also have neutralizing autoantibodies against type I IFNs and are at higher risk of getting life-threatening COVID-19 pneumonia. In patients with autosomal-dominant NF-κB2 deficiency, these autoantibodies are found only in individuals who are heterozygous for variants associated with both transcription (p52 activity) loss of function (LOF) due to impaired p100 processing to generate p52, and regulatory (IκBδ activity) gain of function (GOF) due to the accumulation of unprocessed p100, therefore increasing the inhibitory activity of IκBδ (hereafter, p52 LOF /IκBδ GOF ). By contrast, neutralizing autoantibodies against type I IFNs are not found in individuals who are heterozygous for NFKB2 variants causing haploinsufficiency of p100 and p52 (hereafter, p52 LOF /IκBδ LOF ) or gain-of-function of p52 (hereafter, p52 GOF /IκBδ LOF ). In contrast to patients with APS-1, patients with disorders of NIK, RELB or NF-κB2 have very few tissue-specific autoantibodies. However, their thymuses have an abnormal structure, with few AIRE-expressing medullary thymic epithelial cells. Human inborn errors of the alternative NF-κB pathway impair the development of AIRE-expressing medullary thymic epithelial cells, thereby underlying the production of autoantibodies against type I IFNs and predisposition to viral diseases.

Suggestions

Du même auteur

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

Archive ouverte | Le Voyer, Tom | CCSD

Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency produce autoantibodies that neutralize type I interferons (IFNs)1,2, conferring a predisposition to life-threatening...

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

Archive ouverte | Bastard, Paul | CCSD

International audience. We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-α2 in 10 patients: IFN-α2 only in three, ...

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Archive ouverte | Manry, Jérémy | CCSD

International audience. Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It is important t...

Chargement des enrichissements...